StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)
Stock analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ AKTX opened at $1.09 on Friday. Akari Therapeutics has a one year low of $0.90 and a […]
Stock analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ AKTX opened at $1.09 on Friday. Akari Therapeutics has a one year low of $0.90 and a […]
